Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease
Avanish Tripathi(Indian Institute of Technology Indore), Sushant K. Shrivastava(Indian Institute of Technology BHU), Priyanka Kumari Choubey(Banaras Hindu University), Manish Tripathi(All India Institute of Medical Sciences), Sairam Krishnamurthy(Banaras Hindu University), Santosh Kumar Prajapati(University of South Florida), Piyoosh Sharma(Banaras Hindu University), Prabhash Nath Tripathi(Unknown), Ankit Seth(Banaras Hindu University)
Cited by 72
Related Papers
Comprehensive review of mechanisms of pathogenesis involved in Alzheimer’s disease and potential therapeutic strategies
|Progress in Neurobiology|2018|317
Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory
|European Journal of Medicinal Chemistry|2018|217
Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory
|Bioorganic Chemistry|2018|209
Review of Pharmacotherapeutic Targets in Alzheimer’s Disease and Its Management Using Traditional Medicinal Plants
|Degenerative Neurological and Neuromuscular Disease|2024|136
Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery
|Molecular Diversity|2021|135